Evidence Review

Adlyxin (lixisenatide) for Type 2 Diabetes 

Adlyxin adverse events summary in Evidex by Advera HealthTables in this report include:

  • Clinical trial experience of Adlyxin(lixisenatide) vs. Victoza (liraglutide) and Byetta (exenatide)

  • Comparison of IME-Serious AEs from clinical trials and drug labels of Adlyxin, Victoza, and Byetta

  • IME Serious RxSignals for Victoza and Byetta

  • Harm costs and for Victoza and Byetta

  • RxScore comparison for all Type 2 Diabetes drugs

For full access to this free report, please complete the form on this page.

 

Please note: This is an independent analysis conducted by Advera Health, based upon data and insight generated by the analytical tools of Evidex and other pertinent information gathered at the time of publication. This analysis is not sponsored or influenced by any third party. The inclusion of a particular company, drug, adverse event, class or indication in this report is determined wholly by our quantitative signaling and analytic systems along with our qualitative analysis work.